Researchers find trigger for narcolepsy: study
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Swiss scientists say they have found a trigger for narcolepsy, the health disorder that sparks sudden daytime bouts of tiredness or sleep, in a move that could open up new avenues for treatment.
The protein, called Trib2, is produced by neurones that also secrete the substance which helps keeps people awake, hypocretin, the researchers at Geneva and Lausanne Universities said in a statement.
Narcolepsy, which affects some 0.05 percent of the population on average, has already been associated with a hypocretin deficiency but the exact cause had never been pinpointed.
The researcher team concluded that narcolepsy was the result of an attack by the body's own immune system, after they found high levels of Trib2 antibodies amongst a sample of 120 narcoleptic patients.
The antibodies end up destroying the hypocretic neurones.
Professor Mehdi Tafti, co-director of the sleep laboratory at Vaud University Hospital in Lausanne, said that treatment with immunoglobulin, which is commonly used for auto-immune diseases of the nervous system, had shown "extraordinary results."
The sleep disorder disappeared in most of the patients treated soon after first symptoms, the statement added.
The Swiss researchers hope the discovery could also shed more light on the way the human body handles sleep.
The results were published in the Journal of Clinical Investigation.
axr/pac/co
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments